Shifeng S Mao

6PUBLICATIONS
43CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2026
Immunometabolic effects of oral testosterone for castration-resistant prostate cancer in the ACROBAT trial.

|May 06, 2025
Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

A Mandl, M L Zahurak, N A Metri

|Aug 09, 2024
The survival outcomes of localized low-risk prostate cancer, a population-based study using NCDB.

Shifeng Mao, Arash Samiei, Yue Yin

|Nov 15, 2023
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.

Channing J Paller, Pedro C Barata, Justin Lorentz

|Sep 07, 2022
Urachal carcinoma: A novel staging system utilizing the National Cancer Database.

Vladimir Limonnik, Arash Samiei, Stephen Abel

|Feb 22, 2021
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.

Samuel R Denmeade, Hao Wang, Neeraj Agarwal

Pageof 1

Frequent Collaborators

4 joint publications

Channing J Paller

3 joint publications

Mark C Markowski

2 joint publications

Elisabeth I Heath

2 joint publications

Catherine H Marshall